United States · Platforms & data · Investing.com

Akari Therapeutics shareholders approve increase in shares for 2023 equity plan

Published by Investing.com · United States 1 h ago

Read the full article on Investing.com Sign in to save

MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.investing.com)

Also worth reading

The Motley Fool

These 3 Big Risks Could Cause the Next Bear Market. I'm Investing Anyway.

WisdomTree outlines plan to launch 15 to 20 Atlantic House products over 18 to 24 months as Onchain platform expands partnerships

In a wild October for markets, these stocks were the biggest winners and losers

Toncoin (TON) Price Prediction 2025, 2026, 2027-2030

SmartFinancial Approves Regular Quarterly Cash Dividend

Cathie Wood's Ark warns of growing threat after Binance hack